Literature DB >> 8015571

The cost of a successful delivery with in vitro fertilization.

P J Neumann1, S D Gharib, M C Weinstein.   

Abstract

BACKGROUND: The use of in vitro fertilization has engendered considerable debate about who should have the procedure, whether health insurance should cover the cost, and if so, to what extent. We investigated the cost of a successful delivery with in vitro fertilization.
METHODS: We calculated the cost per successful delivery with in vitro fertilization (defined as at least one live birth) for a general population of couples undergoing in vitro fertilization and for two subgroups: couples with a diagnosis of tubal disease (who have a better chance of success), and couples in which the woman is over the age of 40 years and the man has a low sperm count (who have a lower chance of success). Information on charges per cycle of in vitro fertilization was obtained from six facilities across the country; delivery rates with this procedure were estimated from the literature.
RESULTS: On average, the cost incurred per successful delivery with in vitro fertilization increases from $66,667 for the first cycle of in vitro fertilization to $114,286 by the sixth cycle. The cost increases because with each cycle in which fertilization fails, the probability that a subsequent effort will be successful declines. Sensitivity analyses indicated that the cost per delivery ranges from $44,000 to $211,940. For couples with a better chance of successful in vitro fertilization (i.e., those with a diagnosis of tubal disease), it costs $50,000 per delivery for the first cycle and $72,727 for the sixth. For couples in which the woman is older and there is a diagnosis of male-factor infertility, the cost rises from $160,000 for the first cycle to $800,000 for the sixth.
CONCLUSIONS: The debate about insurance coverage for in vitro fertilization must take into account ethical judgments and social values. But analyses of costs and cost effectiveness help elucidate the economic implications of using in vitro fertilization and thus inform the policy discussion.

Entities:  

Mesh:

Year:  1994        PMID: 8015571     DOI: 10.1056/NEJM199407283310406

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  23 in total

1.  Reflections on the cost-effectiveness of recombinant FSH in assisted reproduction. The clinician's perspective.

Authors:  J Balasch; P N Barri
Journal:  J Assist Reprod Genet       Date:  2001-02       Impact factor: 3.412

Review 2.  Infertility: from a personal to a public health problem.

Authors:  A T Fidler; J Bernstein
Journal:  Public Health Rep       Date:  1999 Nov-Dec       Impact factor: 2.792

Review 3.  Bioethics for clinicians: 26. Assisted reproductive technologies.

Authors:  L Shanner; J Nisker
Journal:  CMAJ       Date:  2001-05-29       Impact factor: 8.262

4.  Utilization of infertility treatments: the effects of insurance mandates.

Authors:  Marianne P Bitler; Lucie Schmidt
Journal:  Demography       Date:  2012-02

5.  The medical marketplace and the diffusion of technologies.

Authors:  R H Blank
Journal:  Health Care Anal       Date:  1996-11

6.  Urology Update from Jackson Hole: Highlights from the 3rd Annual Jackson Hole Summer Urologic Conference July 28-August 3, 2001, Jackson Hole, WY.

Authors:  Michael K Brawer
Journal:  Rev Urol       Date:  2002

Review 7.  Public financing of IVF: a review of policy rationales.

Authors:  Philipa Mladovsky; Corinna Sorenson
Journal:  Health Care Anal       Date:  2009-04-03

Review 8.  Cost and efficacy comparison of in vitro fertilization and tubal anastomosis for women after tubal ligation.

Authors:  Lauren B Messinger; Connie E Alford; John M Csokmay; Melinda B Henne; Sunni L Mumford; James H Segars; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2015-05-23       Impact factor: 7.329

Review 9.  Is screening for Chlamydia trachomatis infection cost effective?

Authors:  J Paavonen
Journal:  Genitourin Med       Date:  1997-04

10.  IVF cycle cost estimation using Activity Based Costing and Monte Carlo simulation.

Authors:  Lucia Cassettari; Marco Mosca; Roberto Mosca; Fabio Rolando; Mauro Costa; Valerio Pisaturo
Journal:  Health Care Manag Sci       Date:  2014-04-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.